Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
Hamid Tavakoli1, Kate M Johnson1, J Mark FitzGerald2, Don D Sin3, Andrea S Gershon4, Tetyana Kendzerska5, Mohsen Sadatsafavi1,2 On behalf of the Canadian Respiratory Research Network1Respiratory Evaluation Sciences Program, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada; 2Institute for Heart and Lung Health, Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada; 3Centre for Heart Lung Innovation (the James Hogg Research Centre), St. Paul’s Hospi... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2019 |
Reihe/Periodikum: | International Journal of COPD, Vol Volume 14, Pp 2003-2013 (2019) |
Verlag/Hrsg.: |
Dove Medical Press
|
Schlagwörter: | COPD / Medication / Cost / Trend / SABA / ICS / LABA / LAMA / SAMA / Diseases of the respiratory system / RC705-779 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27640574 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doaj.org/article/ae0a41cfac7f4a10afe8012b5f4a7a56 |